Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply ...

Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...

The chart below compares the forward price to earnings (P/E) ratio of AstraZeneca to multiples in a peer set of leading ...

On a spring day this year, the New Jersey State Policemen’s Benevolent Association received three unusual visitors: ...

"You have a choice between — you don't have the choice, you're either given KFC or Big Macs." Weight-loss companies could get ...

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

The excitement around the new weight-loss industry is overtaking other disease areas and portfolios for publicly traded ...

The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

Danish pharmaceutical company Novo Nordisk announced last weekend that Wegovy, the weight-loss version of the company's ...

Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity.